Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2025-12-24 @ 4:20 PM
NCT ID:
NCT05269966
Eligibility Criteria:
Inclusion Criteria:
* Female or male, treatment naïve patient with ≥50 years of age, with neovascular age-related macular degeneration (nAMD).
* Patient or legally acceptable representative (LAR) willing to voluntarily provide signed informed consent for participation in the study.
Note: In case where both eyes are affected, data of only one eye \['study eye'\] will be recorded. Selection of the eye to be considered for the purpose of the study \[referred to as 'study eye'\] will be as per the Investigator's discretion.
Exclusion Criteria:
* Patients fulfilling any of the following criteria are not eligible for this study:
* Patient having other eye diseases that could compromise the VA.
* Patient with existing or suspected ocular or periocular infection in the study eye.
* Patient with an existing intraocular inflammation (IOI).
* Patient with uncontrolled glaucoma defined as intraocular pressure \> 25 mmHg despite treatment with anti-glaucoma medication, or according to Investigator's judgment.
* Patient who has undergone intraocular surgery within 3 months prior to enrollment in this study.
* Patient having scar, fibrosis and atrophy involving the center of the fovea in the study eye.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
100 Years
Study:
NCT05269966
Study Brief:
Protocol Section:
NCT05269966